Hamburg Acute Renal Injury Study (HARIS)
Recruiting now
Conditions studied: Acute Kidney Injury, Acute Kidney Injury (AKI)
In brief
The Hamburg Acute Renal Injury Study (HARIS) is a prospective observational cohort study aimed at investigating the mechanisms, risk factors, and clinical determinants of acute kidney injury (AKI) trajectories and consequences.
Key facts
- Study ID
- NCT07338669
- Run by
- Universitätsklinikum Hamburg-Eppendorf
- People needed
- 1000
- Starts
- 2025-09-16
- Expected to finish
- 2030-09-01
- Last updated by the study team
- 2026-01-14
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Hospitalized individuals with acute kidney injury (AKI), defined by the 2012 Kidney Disease: Improving Global Outcomes (KDIGO) criteria or hospitalized individuals with acute illness who have not developed AKI (control group)
- Age ≥ 18 years at time of enrollment
- Personally signed informed consent
You may not qualify if…
- None
Where it is running
- Universitätsklinikum Hamburg-Eppendorf — Hamburg, Germany (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.